Assessment of IgG3 as a serological exposure marker for <i>Plasmodium vivax</i> in areas with moderate-high malaria transmission intensity.
Tayipto Y, Rosado J, Gamboa D, White MT, Kiniboro B, Healer J, Opi DH, Beeson JG, Takashima E, Tsuboi T, Harbers M, Robinson L, Mueller I, Longley RJ
Lessons for improved COVID-19 surveillance from the scale-up of malaria testing strategies.
Kerr G, Robinson LJ, Russell TL, Macdonald J
COVID-19
Piperaquine Pharmacokinetic and Pharmacodynamic Profiles in Healthy Volunteers of Papua New Guinea after Administration of Three-Monthly Doses of Dihydroartemisinin-Piperaquine.
Millat-Martínez P, Salman S, Moore BR, Baro B, Page-Sharp M, Batty KT, Robinson LJ, Pomat W, Karunajeewa H, Laman M, Manning L, Mitjà O, Bassat Q
Genomic Sequencing of Dengue Virus Strains Associated with Papua New Guinean Outbreaks in 2016 Reveals Endemic Circulation of DENV-1 and DENV-2.
Jonduo M, Neave MJ, Javati S, Abala D, Bilo E, Kini A, Kumbu J, Laman M, Robinson LJ, Makita L, Susapu M, Pomat W, Abdad MY, Williams DT, Horwood PF
Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trial.
Laman M, Tavul L, Karl S, Kotty B, Kerry Z, Kumai S, Samuel A, Lorry L, Timinao L, Howard SC, Makita L, John L, Bieb S, Wangi J, Albert JM, Payne M, Weil GJ, Tisch DJ, Bjerum CM, Robinson LJ, King CL
STRIVE PNG: using a partnership-based approach in implementation research to strengthen surveillance and health systems in Papua New Guinea.
Farquhar R, Dori A, MacCana S, Tefuarani N, Lavu E, Barry A, Karl S, Makita L, Robinson L, Laman M